Tag: breast cancer diagnostics industry insights

  • Global Breast Cancer Diagnostics Market Trends: Regional Breakdowns and Strategic Insights

    Discover trends, market shifts, and competitive outlooks for the breast cancer diagnostics industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

    What Is the Estimated Market Size of the Breast Cancer Diagnostics Market In 2029?

    In recent years, the market size for breast cancer diagnostics has experienced substantial growth. There is an anticipation of growth from $4.68 billion in 2024 to $5.04 billion in 2025, following a compound annual growth rate (CAGR) of 7.9%. Factors such as awareness and screening campaigns, mammography screening, advancements in technology, genetic testing and a multidisciplinary approach have significantly contributed to the growth in the historical period.

    Expectations are high for the breast cancer diagnostics market to experience significant expansion in the near future. The market value is projected to reach $6.91 billion in 2029, increasing at a compound annual growth rate (CAGR) of 8.2%. The predicted expansion during the forecast period can be linked to the development and rising popularity of personalized medicine, liquid biopsies, 3d mammography (tomosynthesis), artificial intelligence, and machine learning, as well as the growing use of telemedicine and remote consultations. The forecast period is also anticipated to witness trends such as advancements in imaging technologies, the rise of personalised medicine, wider usage of liquid biopsies, and the integration of artificial intelligence and machine learning.

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3284&type=smp

    What Are the Major Market Drivers Behind the Rising Adoption of Breast Cancer Diagnostics Market?

    The rising occurrence of breast cancer necessitates an increase in diagnostic tools, thus escalating the demand for the breast cancer diagnostics market. Recognized as the most prevalent type of cancer, breast cancer affects about 2.1 million women annually and results in the highest number of cancer-related deaths in women. The primary aim of early detection is to escalate the number of cases diagnosed at the initial state, thereby fostering effective treatment strategies which could potentially reduce the mortality rate from breast cancer. As an illustration, the American Cancer Society, a US-based organization dedicated to eradicating cancer, reported in January 2022 that about 287,850 new invasive breast cancer cases and 51,400 cases of DCIS are expected to be diagnosed among women in the United States this year, with a predicted 43,250 deaths as a result of breast cancer. As such, the increasing rate of breast cancer diagnoses is anticipated to propel the growth of the breast cancer diagnostics market.

    Which Key Market Segments Comprise the Breast Cancer Diagnostics Market and Drive Its Revenue Growth?

    The breast cancer diagnostics market covered in this report is segmented –

    1) By Type: Imaging, Biopsy, Genomic Tests, Blood Tests, Other Types

    2) By Technology: Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Other Technologies

    3) By Cancer Type: BRCA Breast Cancer, ER And PR Breast Cancer, HER 2 Breast Cancer, EGFR Mutation Test Breast Cancer, Other Cancer Types

    4) By Diagnostic Type: Ionizing Breast Imaging Technologies, Non-ionizing Imaging Technologies

    5) By End Users: Hospitals And Clinics, Cancer Research Centers, Diagnostic Laboratories, Ambulatory Surgical Centers

    Subsegments:

    1) By Imaging: Mammography, Ultrasound Imaging, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Tomosynthesis

    2) By Biopsy: Needle Biopsy, Core Needle Biopsy, Fine Needle Aspiration Biopsy (FNA), Stereotactic Biopsy

    3) By Genomic Tests: Oncotype DX, MammaPrint, PAM50, BRCA1 Or 2 Testing

    4) By Blood Tests: Liquid Biopsy, Circulating Tumor DNA (ctDNA) Tests, Circulating Tumor Cells (CTCs) Tests

    5) By Other Types: Hormone Receptor Tests, HER2 Tests, Genetic Mutation Testing

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=3284&type=smp

    Which Areas Are Leading Regions in the Breast Cancer Diagnostics Market Expansion Across the Globe?

    North America was the largest region in the breast cancer diagnostics market in 2023. Asia-Pacific was the second largest region in the breast cancer diagnostics industry. The regions covered in the breast cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    What Are the Strategic Trends Steering the Breast Cancer Diagnostics Market Direction?

    Progression in technology is a significant trend in the breast cancer diagnostics market. There have been developments in numerous new methods that can be applied in detecting and treating breast cancer. Breast tomosynthesis, also known as 3D mammography, creates images of the breast from multiple perspectives and converts them into a 3-D model. Niramai, an Indian health-tech firm, in September 2022, introduced an inventive solution named Thermalytix. This is an automated tool for breast cancer screening and diagnosis, merging thermal imaging and AI.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/breast-cancer-diagnostics-global-market-report

    How Is the Breast Cancer Diagnostics Market Conceptually Defined?

    Breast cancer diagnostics refer to the various methods, tests, and procedures used to detect and diagnose breast cancer in individuals. These diagnostics help identify the presence of cancer cells in breast tissue, determine the stage of cancer, and guide treatment decisions.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3284

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • How the Breast Cancer Diagnostics Market Will Grow: Key Trends, Market Size, and Opportunities Beyond 2025

    How the Breast Cancer Diagnostics Market Will Grow: Key Trends, Market Size, and Opportunities Beyond 2025

    2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

    Which Primary Drivers Are Supporting the Continued Market Growth of theBreast Cancer Diagnostics Market?

    The breast cancer diagnostics market is expected to grow due to the rising incidence of breast cancer. With breast cancer being the most common cancer among women, early detection plays a key role in reducing mortality rates. In 2022, the American Cancer Society estimated 287,850 new cases of invasive breast cancer in the U.S., making breast cancer diagnosis an urgent and necessary component of healthcare. The increasing need for diagnostic equipment to detect breast cancer at an early stage will drive market growth.

    Get Your Free Sample Report Now – Explore Exclusive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3284&type=smp

    How Will the Growth Rate of theBreast Cancer Diagnostics Market Impact Industry Trends by 2034?

    The breast cancer diagnostics market has experienced notable growth. It is expected to increase from $4.68 billion in 2024 to $5.04 billion in 2025, at a CAGR of 7.9%. This expansion has been driven by screening initiatives, widespread use of mammography, innovation in diagnostic technology, the rise in genetic testing, and integrated medical approaches.

    The breast cancer diagnostics market will grow to $6.91 billion by 2029, at a CAGR of 8.2%. This growth is largely driven by innovations in imaging technologies, personalized medicine, liquid biopsies, and AI-driven diagnostic solutions. The development of 3D mammography (tomosynthesis) and telemedicine solutions will be key trends.

    You can Directly Purchase the Report Here:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3284

    How Are Consumer Market Innovations Shaping the Current and Future Landscape of theBreast Cancer Diagnostics Market?

    Technological developments are significantly impacting the breast cancer diagnostics market. New diagnostic tools have emerged, such as 3D mammography, or breast tomosynthesis, which compiles multiple images to create a 3D breast model. In September 2022, Niramai, an Indian health-tech firm, introduced Thermalytix—a breast cancer detection solution that uses a combination of thermal imaging and artificial intelligence for automated screening and diagnosis.

    Who Are the Key Market Players Influencing the Growth of the Corn and Breast Cancer Diagnostics Industry?

    Major companies operating in the breast cancer diagnostics market include Abbott Laboratories, Myriad Genetics Inc., Hologic Inc., Koninklijke Philips N.V., Fujifilm Holdings Corporation, GE Healthcare, Thermo Fisher Scientific Inc., Siemens AG, NanoString Technologies Inc., Gamma Medica Inc., Aurora Imaging Technology Inc., Dilon Technologies Inc., Exact Sciences Corporation, F. Hoffmann-La Roche Ltd, Micrima Limited, Provista Diagnostics Inc., Leica Biosystems Nussloch GmbH, bioTheranostics Inc., Bio-Rad Laboratories Inc., Illumina Inc., Biocept Inc., Epigenomics AG, AstraZeneca plc, Quest Diagnostics Incorporated, Agilent Technologies Inc., Cepheid, Guardant Health Inc., Invitae Corporation, Natera Inc., NeoGenomics Laboratories Inc., Oncocyte Corporation, PerkinElmer Inc., Sysmex Corporation, Veracyte Inc.

    Order Your Report Now For A Swift Delivery:

    https://www.thebusinessresearchcompany.com/report/breast-cancer-diagnostics-global-market-report

    Which Key Market Segments Comprise the Breast Cancer Diagnostics Market and Drive Its Revenue Growth?

    The breast cancer diagnostics market covered in this report is segmented –

    1) By Type: Imaging, Biopsy, Genomic Tests, Blood Tests, Other Types

    2) By Technology: Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Other Technologies

    3) By Cancer Type: BRCA Breast Cancer, ER And PR Breast Cancer, HER 2 Breast Cancer, EGFR Mutation Test Breast Cancer, Other Cancer Types

    4) By Diagnostic Type: Ionizing Breast Imaging Technologies, Non-ionizing Imaging Technologies

    5) By End Users: Hospitals And Clinics, Cancer Research Centers, Diagnostic Laboratories, Ambulatory Surgical Centers

    Subsegments:

    1) By Imaging: Mammography, Ultrasound Imaging, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Tomosynthesis

    2) By Biopsy: Needle Biopsy, Core Needle Biopsy, Fine Needle Aspiration Biopsy (FNA), Stereotactic Biopsy

    3) By Genomic Tests: Oncotype DX, MammaPrint, PAM50, BRCA1 Or 2 Testing

    4) By Blood Tests: Liquid Biopsy, Circulating Tumor DNA (ctDNA) Tests, Circulating Tumor Cells (CTCs) Tests

    5) By Other Types: Hormone Receptor Tests, HER2 Tests, Genetic Mutation Testing

    Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

    https://www.thebusinessresearchcompany.com/customise?id=3284&type=smp

    Which Regions Are Emerging as Leaders in the Breast Cancer Diagnostics Market?

    North America was the largest region in the breast cancer diagnostics market in 2023. Asia-Pacific was the second largest region in the breast cancer diagnostics industry. The regions covered in the breast cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Browse Through More Reports Similar to the Global Breast Cancer Diagnostics Market 2025, By The Business Research Company:

    Breast Cancer Drugs Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/breast-cancer-drugs-global-market-report

    Oncology Biosimilars Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/oncology-biosimilar-global-market-report

    Cancer Diagnostics Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Unlocking the Future of the Breast Cancer Diagnostics Market: Growth Rate, Key Trends, and Opportunities for 2025-2034

    Unlocking the Future of the Breast Cancer Diagnostics Market: Growth Rate, Key Trends, and Opportunities for 2025-2034

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What key factors are powering the surge in the breast cancer diagnostics market right now?

    The market size for breast cancer diagnostics has seen significant growth in the recent past. The projection is that it will surge from $4.68 billion in 2024 to $5.04 billion in 2025, with a compound annual growth rate (CAGR) of 7.9%. Factors such as awareness campaigns, mammography screening, technological progress, genetic testing, and a multidisciplinary approach have all contributed to this growth during the historic period.

    How fast Is the breast cancer diagnostics market expected to grow, and what’s its future value?

    The market size for breast cancer diagnostics is anticipated to experience substantial growth in the coming years, reaching $6.91 billion in 2029 with a compound annual growth rate (CAGR) of 8.2%. This projected increase during the forecast period can be linked to factors such as personalized medicine, liquid biopsies, 3D mammography (tomosynthesis), AI and machine learning, as well as telemedicine and remote consultations. Moreover, the forecast period will witness prominent trends such as advancements in imaging technologies, the rise of personalized medicine, the use of liquid biopsies, the application of AI and machine learning.

    Get your breast cancer diagnostics market report here!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3284&type=smp

    What are the leading drivers of growth in the breast cancer diagnostics market?

    The surge in the occurrence of breast cancer necessitates an increase in diagnostic equipment, thereby escalating the demand in the breast cancer diagnostics market. With breast cancer being the most prevalent type of cancer, affecting 2.1 million women annually and accounting for the highest number of cancer-related deaths in women, the emphasis has shifted towards early diagnosis. The aim is to detect a higher percentage of breast cancers in their initial stages to provide more effective treatment and lower the mortality rate. For instance, the American Cancer Society, a US-based health organization committed to the eradication of cancer, reported in January 2022, an estimated 287,850 new cases of invasive breast cancer, along with 51,400 cases of DCIS. In addition to this, an expected 43,250 breast cancer fatalities are predicted in the United States for the year 2022. Consequently, the escalating incidence of breast cancer is anticipated to propel the growth of the breast cancer diagnostics market.

    What are the key segments defining the breast cancer diagnostics market?

    The breast cancer diagnostics market covered in this report is segmented –

    1) By Type: Imaging, Biopsy, Genomic Tests, Blood Tests, Other Types

    2) By Technology: Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Other Technologies

    3) By Cancer Type: BRCA Breast Cancer, ER And PR Breast Cancer, HER 2 Breast Cancer, EGFR Mutation Test Breast Cancer, Other Cancer Types

    4) By Diagnostic Type: Ionizing Breast Imaging Technologies, Non-ionizing Imaging Technologies

    5) By End Users: Hospitals And Clinics, Cancer Research Centers, Diagnostic Laboratories, Ambulatory Surgical Centers

    Subsegments:

    1) By Imaging: Mammography, Ultrasound Imaging, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Tomosynthesis

    2) By Biopsy: Needle Biopsy, Core Needle Biopsy, Fine Needle Aspiration Biopsy (FNA), Stereotactic Biopsy

    3) By Genomic Tests: Oncotype DX, MammaPrint, PAM50, BRCA1 Or 2 Testing

    4) By Blood Tests: Liquid Biopsy, Circulating Tumor DNA (ctDNA) Tests, Circulating Tumor Cells (CTCs) Tests

    5) By Other Types: Hormone Receptor Tests, HER2 Tests, Genetic Mutation Testing

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3284&type=smp

    Who are the key players steering the development of the breast cancer diagnostics market?

    Major companies operating in the breast cancer diagnostics market include Abbott Laboratories, Myriad Genetics Inc., Hologic Inc., Koninklijke Philips N.V., Fujifilm Holdings Corporation, GE Healthcare, Thermo Fisher Scientific Inc., Siemens AG, NanoString Technologies Inc., Gamma Medica Inc., Aurora Imaging Technology Inc., Dilon Technologies Inc., Exact Sciences Corporation, F. Hoffmann-La Roche Ltd, Micrima Limited, Provista Diagnostics Inc., Leica Biosystems Nussloch GmbH, bioTheranostics Inc., Bio-Rad Laboratories Inc., Illumina Inc., Biocept Inc., Epigenomics AG, AstraZeneca plc, Quest Diagnostics Incorporated, Agilent Technologies Inc., Cepheid, Guardant Health Inc., Invitae Corporation, Natera Inc., NeoGenomics Laboratories Inc., Oncocyte Corporation, PerkinElmer Inc., Sysmex Corporation, Veracyte Inc.

    What emerging trends are influencing the growth of the breast cancer diagnostics market?

    The progression of technology is a significant trend in the market for breast cancer diagnostics. Numerous innovative methods, suitable for diagnosing and treating breast cancer, have been developed recently. 3D mammography, or breast tomosynthesis, is able to create a 3-D model of the breast by photographing it from various angles. Niramai, an Indian Health-Tech firm, unveiled a cutting-edge solution known as Thermalytix in September 2022. This is an automatic screening and diagnostic instrument for breast cancer, merging thermal imaging and AI.

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3284

    Which regions are most influential in expanding the breast cancer diagnostics market?

    North America was the largest region in the breast cancer diagnostics market in 2023. Asia-Pacific was the second largest region in the breast cancer diagnostics industry. The regions covered in the breast cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Browse Through More Similar Reports By The Business Research Company:

    Breast Cancer Drugs Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/breast-cancer-drugs-global-market-report

    Oncology Biosimilars Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/oncology-biosimilar-global-market-report

    Cancer Diagnostics Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Key Trends and Insights into the Breast Cancer Diagnostics Market: Growth Rate and Opportunities to 2034

    Key Trends and Insights into the Breast Cancer Diagnostics Market: Growth Rate and Opportunities to 2034

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What Future CAGR is Anticipated for the Breast Cancer Diagnostics Market Over the 2025–2034 Period?

    The market size for breast cancer diagnostics has seen significant growth in the recent past. The projection is that it will surge from $4.68 billion in 2024 to $5.04 billion in 2025, with a compound annual growth rate (CAGR) of 7.9%. Factors such as awareness campaigns, mammography screening, technological progress, genetic testing, and a multidisciplinary approach have all contributed to this growth during the historic period.

    The market size for breast cancer diagnostics is anticipated to experience substantial growth in the coming years, reaching $6.91 billion in 2029 with a compound annual growth rate (CAGR) of 8.2%. This projected increase during the forecast period can be linked to factors such as personalized medicine, liquid biopsies, 3D mammography (tomosynthesis), AI and machine learning, as well as telemedicine and remote consultations. Moreover, the forecast period will witness prominent trends such as advancements in imaging technologies, the rise of personalized medicine, the use of liquid biopsies, the application of AI and machine learning.

    How Are the key drivers expanding the growth of the Breast Cancer Diagnostics Market?

    The surge in the occurrence of breast cancer necessitates an increase in diagnostic equipment, thereby escalating the demand in the breast cancer diagnostics market. With breast cancer being the most prevalent type of cancer, affecting 2.1 million women annually and accounting for the highest number of cancer-related deaths in women, the emphasis has shifted towards early diagnosis. The aim is to detect a higher percentage of breast cancers in their initial stages to provide more effective treatment and lower the mortality rate. For instance, the American Cancer Society, a US-based health organization committed to the eradication of cancer, reported in January 2022, an estimated 287,850 new cases of invasive breast cancer, along with 51,400 cases of DCIS. In addition to this, an expected 43,250 breast cancer fatalities are predicted in the United States for the year 2022. Consequently, the escalating incidence of breast cancer is anticipated to propel the growth of the breast cancer diagnostics market.

    Get Your Free Sample of the Global Breast Cancer Diagnostics Market Report Now!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3284&type=smp

    Who Are the Influential Players Fueling Innovation and Growth in the Breast Cancer Diagnostics Market?

    Major companies operating in the breast cancer diagnostics market include Abbott Laboratories, Myriad Genetics Inc., Hologic Inc., Koninklijke Philips N.V., Fujifilm Holdings Corporation, GE Healthcare, Thermo Fisher Scientific Inc., Siemens AG, NanoString Technologies Inc., Gamma Medica Inc., Aurora Imaging Technology Inc., Dilon Technologies Inc., Exact Sciences Corporation, F. Hoffmann-La Roche Ltd, Micrima Limited, Provista Diagnostics Inc., Leica Biosystems Nussloch GmbH, bioTheranostics Inc., Bio-Rad Laboratories Inc., Illumina Inc., Biocept Inc., Epigenomics AG, AstraZeneca plc, Quest Diagnostics Incorporated, Agilent Technologies Inc., Cepheid, Guardant Health Inc., Invitae Corporation, Natera Inc., NeoGenomics Laboratories Inc., Oncocyte Corporation, PerkinElmer Inc., Sysmex Corporation, Veracyte Inc.

    What Impact Are Industry Trends Having on the Breast Cancer Diagnostics Market’s Future Prospects?

    The progression of technology is a significant trend in the market for breast cancer diagnostics. Numerous innovative methods, suitable for diagnosing and treating breast cancer, have been developed recently. 3D mammography, or breast tomosynthesis, is able to create a 3-D model of the breast by photographing it from various angles. Niramai, an Indian Health-Tech firm, unveiled a cutting-edge solution known as Thermalytix in September 2022. This is an automatic screening and diagnostic instrument for breast cancer, merging thermal imaging and AI.

    Get Instant Access to the Global Breast Cancer Diagnostics Market Report with Swift Delivery!

    https://www.thebusinessresearchcompany.com/report/breast-cancer-diagnostics-global-market-report

    How Are Key Segments Defining the Competitive Landscape of the Breast Cancer Diagnostics Market?

    The breast cancer diagnostics market covered in this report is segmented –

    1) By Type: Imaging, Biopsy, Genomic Tests, Blood Tests, Other Types

    2) By Technology: Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Other Technologies

    3) By Cancer Type: BRCA Breast Cancer, ER And PR Breast Cancer, HER 2 Breast Cancer, EGFR Mutation Test Breast Cancer, Other Cancer Types

    4) By Diagnostic Type: Ionizing Breast Imaging Technologies, Non-ionizing Imaging Technologies

    5) By End Users: Hospitals And Clinics, Cancer Research Centers, Diagnostic Laboratories, Ambulatory Surgical Centers

    Subsegments:

    1) By Imaging: Mammography, Ultrasound Imaging, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Tomosynthesis

    2) By Biopsy: Needle Biopsy, Core Needle Biopsy, Fine Needle Aspiration Biopsy (FNA), Stereotactic Biopsy

    3) By Genomic Tests: Oncotype DX, MammaPrint, PAM50, BRCA1 Or 2 Testing

    4) By Blood Tests: Liquid Biopsy, Circulating Tumor DNA (ctDNA) Tests, Circulating Tumor Cells (CTCs) Tests

    5) By Other Types: Hormone Receptor Tests, HER2 Tests, Genetic Mutation Testing

    What Regions Are Leading the Growth Trajectory of the Breast Cancer Diagnostics Market?

    North America was the largest region in the breast cancer diagnostics market in 2023. Asia-Pacific was the second largest region in the breast cancer diagnostics industry. The regions covered in the breast cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    What Are the Key Characteristics That Define the Breast Cancer Diagnostics Market?

    Breast cancer diagnostics refer to the various methods, tests, and procedures used to detect and diagnose breast cancer in individuals. These diagnostics help identify the presence of cancer cells in breast tissue, determine the stage of cancer, and guide treatment decisions.

    Browse Through More Similar Reports By The Business Research Company:

    Breast Cancer Drugs Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/breast-cancer-drugs-global-market-report

    Oncology Biosimilars Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/oncology-biosimilar-global-market-report

    Cancer Diagnostics Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on: